Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. A generic version of Xarelto (rivaroxaban) recently became ...
Johnson & Johnson and Bayer’s wide-spanning VOYAGER PAD study continues to be a gold mine for proving its Xarelto’s worth in several subsets of patients with peripheral artery disease (PAD). New ...
A new oral suspension formulation of Xarelto has also been approved by the FDA. The Food and Drug Administration (FDA) has approved Xarelto ® (rivaroxaban) for 2 new pediatric indications: treatment ...
RARITAN, N.J., Dec. 20, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results